Form 4 for NVCR NovoCure Ltd
Accepted 2023-11-08 00:00:00 ET · period of report 2023-11-07 · accession 0001562180-23-007594 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-08 | 2023-11-07 | NVCR | Shah Pritesh | Chief Growth Off | S - Sale | $12.65 | -382 | 124.5K | -0.3% | -$4,832 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2023-11-07 | S | D | 382 | $12.65 | 124,511 | D | — | — | (F1) Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah. |